Crystalline 3-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate | Patent Publication Number 20030130292

US 20030130292 A1
Patent NumberUS 06965027 B2
Application Number10310078
Filled DateDec 4, 2002
Priority DateDec 6, 2001
Publication DateJul 10, 2003
Original AssigneePfizer
Current AssigneePfizer Legal Division 2
Inventor/ApplicantsZheng J. Li
Mark E. Flanagan
Zheng J. Li
Mark E. Flanagan
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.